Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DFFN The Well kept secret: Brain cancer study...
Source: https://www.diffusionpharma.com/brain-cancer-program/
Like and view!
DFFN Zacks SCR report and valuation. Price Target: $2.00 per share.
Report: https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_05142021_DFFN_Bautz.pdf
DFFN Beautiful reverse chart!
Chart: https://schrts.co/TxWvfzYw
DFFN Beautiful reverse chart!
Chart: https://schrts.co/TxWvfzYw
DFFN They are due to provide results of their important TCOM study during May or June. I think it is a clear buy with a target of $1.50 per share.
DFFN I bought a tone of shares.
Good morning all
Collapse in cryptocurrencies...
Tomorrow red day in Asian and Europe markets...
I sold my all shares... I don't like today charts... Good luck...
SLRX 6 strong catalysts in 2021
SLRX 6 strong catalysts in 2021
SLRX 3 strong catalysts in H1 2021...
http://investors.salariuspharma.com/static-files/84a02ee3-efa8-4c2b-8227-29f5ace442f3
SLRX 3 strong catalysts in H1 2021...
http://investors.salariuspharma.com/static-files/84a02ee3-efa8-4c2b-8227-29f5ace442f3
AEZS Alert!! Breakout with volume!
SLRX alert! Break MA200!!!
Chart: https://schrts.co/RCxYEahW
DFFN I expect News about covid study in april...
SLRX Next run to $3...
$DFFN $5 this week... Strong volume...
$AEZS $SLRX $DFFN for this week...
SLRX Possible best micro Biotech of 2021. 9 catalysts in 2021.
AXAS for long term
ARLP for long term
DFFN I bought shares. Hypoxia study for COVID19... I like...
SLRX Catalysts in 2021, Golden Cross Pattern, Strong volume...
SLRX go to double digit...
SLRX OCGN 2 BEST biotechs for this week
http://www.bolsatrading.eu/2021/02/by-jorge-aura-biopharmaceutical-sector.html?m=1
AXAS Oil Stock... Breakout today!
Remember that: TTNP only 9MM float
SLRX Strong accumulation and Golden Cross Pattern...
Good session for SLRX. This stock has a low float with only 19MM shares.
This biotech has two phase I cancer treatments based on the protein inhibitor LSD1. This system is the most innovative and promising thing currently available against cancer. Salarius pharma is one of the few companies in the market that has studies with these inhibitors. The long-term target price is above $10.
An important factor is that the former investors of Flex pharma (made a merger with Salarius Pharma) have warrants in place with a conversion price at $15. This means that all parties will do their best to reach that price.
It is possibly one of the market opportunities with the most potential in the medium term.
Best regards and good luck.
AHT: A very punished and undervalued stock. When this stock is 100% operational, it could provide a dividend yield of more than 25% at current prices. AHT has a significant drop after the reverse split. You can see that many important investment funds are taking positions. I think it is a jewel for the long term.
Thanks for your opinion.
SLRX +27% with volume. I already warned you...
SLRX Ridiculous Cap With only $30MM
TTNP TRADE one week with accumulation... Low float...
AHT Big Speculation here. This stock like wallstreetbets...
AXAS Oil Stock with Low float
AEZS Nice UP